Home / Dermatology
Dermatology
| 3 min read
Investigative monoclonal antibody shows potential for eczema relief
| 3 min read
With results from its Phase 2B study to be announced soon, Scioderm President and CEO Robert Ryan previewed for DDNews
why he hopes the company may soon achieve its mission to bringing relief to patients who suffer from Epidermolysis Bullosa (EB)
| 3 min read
KYTHERA Biopharmaceuticals announces FDA acceptance of ATX-101
New Drug Application
| 3 min read
Amgen and AstraZeneca announce positive results from Phase 3 study of
brodalumab for moderate to severe plaque psoriasis
| 3 min read
AbbVie presents results from study of investigational compound in patients with glioblastoma at ASCO Annual Meeting
| 3 min read
Nitric oxide-based product provides basis for a fast-acting and well-tolerated solution
| 3 min read
KYTHERA acquires rights to ATX-101
outside of the U.S. and Canada from Bayer Consumer Care
| 3 min read
Nitric oxide-based therapy shows statistically significant results in only four weeks
| 1 min read
Phenomenex announces a new 30 mm internal diameter (I.D.) Kinetex
core-shell 5-micron column in Axia hardware for preparative HPLC and SFC in pharmaceutical lab-scale purification.
| 1 min read
Molecular Devices announced today the launch of ImageXpress Micro XLS System, the latest improvement to its high-content screening portfolio.
| 1 min read
Accelrys Insight and
Accelrys Insight for Excel offer research scientists an entirely new way of accessing, visualizing and analyzing data that is locked in disparate locations
across internal discovery teams and networked external partners, helping to lower long-standing barriers to bringing innovative therapeutics to market faster
and more cost effectively.
